# T. Rowe Price Capital Appreciation I (TRAIX)

> Source: Nexqual · https://nexqual.com/TRAIX · data as of 2026-10-24 00:04 UTC · cite as "Nexqual, T. Rowe Price Capital Appreciation I (TRAIX), nexqual.com/TRAIX" · informational, not investment advice.

**Price:** USD 39.01 (-0.31% on the day) · last close of Oct 23, 2026; US market closed, not a live price. Prev close 39.13 · day 39.01–39.01 · 52w 33.93–39.34 · market cap null · NAS

## Key facts
- Total return with dividends: 1Y +9.1% vs S&P 500 +13.4%; 5Y +47.0% vs S&P 500 +76.9%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-24) | 5Y (from 2021-10-25) |
|---|---|---|
| Total return | +9.1% | +47.0% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +9.1% | +8.0% |
| Volatility (annualized) | 8.0% | 10.8% |
| Max drawdown | -6.3% (Jan 2026→Mar 2026) | -16.8% (Dec 2021→Oct 2022) |

## Peers
THISX (T. Rowe Price Health Sciences F) USD 97.39 +0.00% · RPTIX (T. Rowe Price Mid-Cap Growth Fu) USD 101.29 -0.00% · TTMIX (T. Rowe Price Communications & ) USD 122.68 -0.00% · PDGIX (T. Rowe Price Dividend Growth F) USD 90.43 -0.00% · PRUIX (T. Rowe Price Equity Index 500 ) USD 197.93 +0.00%

## More
Full page: https://nexqual.com/TRAIX · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt